Edwards Letting German Centers Stock-Up On Sapien 3 Ahead Of Patent Ruling

As its dispute with Boston Scientific over transcatheter aortic valve replacement technology patents rumbles on, Edwards Lifesciences is offering German interventionalists the option to buy six-months' worth of its Sapien 3 inventory in anticipation of a potential disruption to the supply flow.